On Oct. 9, 2025, Fred Hutch Cancer Center employees with decades of service were honored at a luncheon celebrating their ...

Today, Fred Hutch announced that in 2025 the Obliteride community raised $9.2 million for groundbreaking research. This amount brings Obliteride’s cumulative fundraising total to more than $67 million ...

A new $5.2 million grant from the Washington Research Foundation will help develop a new clinical trials program between Fred ...

As chief medical officer, Tom Purcell, MD, MBA, is overseeing an organization-wide initiative to improve the delivery of care ...

New Fred Hutch Cancer Center viral immunologist Dr. Paul Thomas is working to turn the "incredible potential" of the immune ...

SEATTLE – October 27, 2025 –Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they ...

Screening is an effective tool for reducing the burden of cancer,” per Fred Hutch public health researcher Chris Li. “But it's a complex process with multiple steps." Unfortunately, many Americans are ...

When Jacqueline Woodfork got sick, the ER physicians found a mass in her chest that turned out to be thymic carcinoma. Woodfork credits her illness — which turned out to be COVID — with saving her ...

Dr. Petros Grivas discusses his new podcast aimed at exploring the latest developments in cancer care and research. He emphasizes the importance of learning from colleagues, engaging with patients, ...

A cancer diagnosis always brings challenges and uncertainty. But for those diagnosed with so-called “rare” cancers — traditionally described as diseases that affect 40,000 or fewer Americans every ...